Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 5:23 pm Purchase |
2025-04-03 | 13G | Karyopharm Therapeutics Inc. KPTI |
Affinity Healthcare Fund, LP | 664,224 7.830% |
664,224 (New Position) |
Filing History |
| 2025-02-12 09:36 am Purchase |
2024-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Adage Capital Management L.P. | 436,737 5.180% |
436,737 (New Position) |
Filing History |
| 2024-11-14 4:22 pm Sale |
2024-09-30 | 13G | Karyopharm Therapeutics Inc. KPTI |
Avidity Partners Management LP | 316,071 3.700% |
-429,846 (-57.63%) |
Filing History |
| 2024-11-12 3:50 pm Unchanged |
2024-09-30 | 13G | Karyopharm Therapeutics Inc. KPTI |
The Vanguard Group | 510,299 6.130% |
0 (Unchanged) |
Filing History |
| 2024-11-04 11:49 am Sale |
2024-09-30 | 13G | Karyopharm Therapeutics Inc. KPTI |
The Vanguard Group | 510,299 6.130% |
-70,378 (-12.12%) |
Filing History |
| 2024-10-25 09:30 am Purchase |
2024-09-30 | 13G | Karyopharm Therapeutics Inc. KPTI |
Highbridge Capital Management, LLC | 649,659 7.200% |
649,659 (New Position) |
Filing History |
| 2024-07-08 4:32 pm Sale |
2024-06-30 | 13G | Karyopharm Therapeutics Inc. KPTI |
BlackRock Inc. BLK |
277,986 3.500% |
-393,459 (-58.60%) |
Filing History |
| 2024-05-23 4:30 pm Purchase |
2024-05-13 | 13G | Karyopharm Therapeutics Inc. KPTI |
J. WOOD CAPITAL ADVISORS LLC | 458,135 5.500% |
458,135 (New Position) |
Filing History |
| 2024-02-14 4:52 pm Sale |
2023-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Palo Alto Investors LP | 340,146 4.450% |
-36,899 (-9.79%) |
Filing History |
| 2024-02-14 10:33 am Sale |
2023-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Avidity Partners Management LP | 745,916 9.500% |
-12,822 (-1.69%) |
Filing History |
| 2024-02-13 5:07 pm Purchase |
2023-12-29 | 13G | Karyopharm Therapeutics Inc. KPTI |
The Vanguard Group | 580,677 7.600% |
580,677 (New Position) |
Filing History |
| 2024-02-12 06:06 am Sale |
2023-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Rubric Capital Management LP | 0 0.000% |
-552,975 (Position Closed) |
Filing History |
| 2024-01-25 1:48 pm Purchase |
2023-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
BlackRock Inc. BLK |
671,445 8.800% |
104,229 (+18.38%) |
Filing History |
| 2024-01-22 1:50 pm Sale |
2023-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
STATE STREET CORP STT |
136,918 1.790% |
-10,573 (-7.17%) |
Filing History |
| 2023-07-10 2:26 pm Sale |
2023-06-30 | 13G | Karyopharm Therapeutics Inc. KPTI |
STATE STREET CORP STT |
147,491 1.940% |
-404,978 (-73.30%) |
Filing History |
| 2023-02-14 4:21 pm Purchase |
2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Palo Alto Investors LP | 377,045 5.000% |
12,348 (+3.39%) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Commodore Capital LP | 129,041 1.700% |
-138,363 (-51.74%) |
Filing History |
| 2023-02-14 3:41 pm Sale |
2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Chione Ltd. | 293,333 3.900% |
-40,000 (-12.00%) |
Filing History |
| 2023-02-14 3:31 pm Purchase |
2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Avidity Partners Management LP | 758,738 9.900% |
1,950 (+0.26%) |
Filing History |
| 2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Rubric Capital Management LP | 552,975 7.330% |
552,975 (New Position) |
Filing History |